Evidence map›Paper›PMID 42799751›Full record

ArticleAbdominal radiology (New York)2026

A rapid automated segmentation method for total kidney volume measurement on unenhanced computed tomography in autosomal dominant polycystic kidney disease.

Yingying Hu, Tianpei Zhao, Yunpeng Gao, Peiyao Zhang, Tongxi Liu, Yue Lin, Shuya Gao, Tongyin Zhang, Yinghao Xu, Bing Li and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in Abdominal radiology (New York), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Yingying HuRadiology, China-Japan Friendship Hospital, 100029, No. 2, Yinghua East Street, Chaoyang District, Beijing, China.
Tianpei ZhaoRadiology, China-Japan Friendship Hospital, 100029, No. 2, Yinghua East Street, Chaoyang District, Beijing, China.
Yunpeng GaoRadiology, China-Japan Friendship Hospital, 100029, No. 2, Yinghua East Street, Chaoyang District, Beijing, China.
Peiyao ZhangRadiology, China-Japan Friendship Hospital, 100029, No. 2, Yinghua East Street, Chaoyang District, Beijing, China.
Tongxi LiuRadiology, China-Japan Friendship Hospital, 100029, No. 2, Yinghua East Street, Chaoyang District, Beijing, China.
Yue LinRadiology, China-Japan Friendship Hospital, 100029, No. 2, Yinghua East Street, Chaoyang District, Beijing, China.
Shuya GaoRadiology, China-Japan Friendship Hospital, 100029, No. 2, Yinghua East Street, Chaoyang District, Beijing, China.
Tongyin ZhangRadiology, China-Japan Friendship Hospital, 100029, No. 2, Yinghua East Street, Chaoyang District, Beijing, China.
Yinghao XuCT Clinical Research Department, CT Business Unit, Canon Medical Systems (China) CO., LTD., 100015, Beijing, China.
Bing LiCT Clinical Research Department, CT Business Unit, Canon Medical Systems (China) CO., LTD., 100015, Beijing, China.ORCID http://orcid.org/0009-0000-6998-4384
Yu ZhangCT Clinical Research Department, CT Business Unit, Canon Medical Systems (China) CO., LTD., 100015, Beijing, China.
Sheng XieRadiology, China-Japan Friendship Hospital, 100029, No. 2, Yinghua East Street, Chaoyang District, Beijing, China.
Li ZhouNephrology, China-Japan Friendship Hospital, 100029, No. 2, Yinghua East Street, Chaoyang District, Beijing, China. zhouli_zryy@163.com.
Hongliang SunRadiology, China-Japan Friendship Hospital, 100029, No. 2, Yinghua East Street, Chaoyang District, Beijing, China. stentorsun@gmail.com.ORCID https://orcid.org/0000-0001-5757-752X

Funding

National Key Clinical Specialty Construction Project (2024-QTL-001)National Key R&D Program of China (No. 2023YFC2508605, 2019YFC1315803)the Noncommunicable Chronic Diseases-National Science and Technology Major Project (2024ZD0529503 /2024ZD0529500)
6 · The paper itself

Abstract

purposeTo develop and validate a fully automated deep learning-based method for total kidney volume (TKV) measurement from unenhanced computed tomography (CT) images in patients with autosomal dominant polycystic kidney disease (ADPKD).

methodsA fully automated kidney segmentation model based on the nnU-Net framework was developed using unenhanced CT images from 236 patients, including 111 patients with ADPKD. The development dataset was divided into a training cohort and an internal testing cohort. An independent cohort of 70 patients with ADPKD was used for validation, including longitudinal scans from 20 patients. The reference standard consisted of semi-automated kidney segmentation followed by slice-by-slice manual correction performed independently by two experienced radiologists. Automated and reference segmentations were compared using the Dice similarity coefficient (DSC), intraclass correlation coefficient (ICC), linear regression and Bland-Altman analysis.

resultsAutomated segmentation exhibited excellent spatial agreement with the reference standard, with a mean DSC of 0.96 ± 0.01 for TKV. Volumetric agreement was near perfect (ICC = 0.999; 95% confidence interval, 0.998-0.999), with minimal bias (-0.14%) and high precision (±2.09%). Longitudinal analysis demonstrated robust agreement for kidney growth assessment (ICC = 0.99; bias, - 0.64%; precision, ± 4.81%). The automated method required approximately 5 s per case, compared with 30 min for expert-assisted reference segmentation.

conclusionThis automated segmentation method enables fast, accurate, and reproducible TKV quantification from unenhanced CT images in patients with ADPKD, offering a clinically feasible alternative to manual volumetric analysis.

Indexed as

Autosomal dominant polycystic kidney diseaseComputed tomographyNnU-NetTotal kidney volume

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.